Thrivent Financial For Lutherans Has $745,000 Stake in Natus Medical Incorporated (BABY)

Thrivent Financial For Lutherans grew its position in Natus Medical Incorporated (NASDAQ:BABY) by 7.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,980 shares of the medical equipment provider’s stock after acquiring an additional 1,410 shares during the period. Thrivent Financial For Lutherans owned about 0.06% of Natus Medical worth $745,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. BlackRock Inc. boosted its holdings in shares of Natus Medical by 0.6% in the second quarter. BlackRock Inc. now owns 4,149,535 shares of the medical equipment provider’s stock valued at $154,779,000 after acquiring an additional 25,340 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Natus Medical by 4.8% in the first quarter. Vanguard Group Inc. now owns 2,274,870 shares of the medical equipment provider’s stock valued at $89,289,000 after acquiring an additional 105,008 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Natus Medical by 105.7% in the first quarter. Wellington Management Group LLP now owns 1,795,094 shares of the medical equipment provider’s stock valued at $70,457,000 after acquiring an additional 922,268 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Natus Medical by 2.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,401,566 shares of the medical equipment provider’s stock valued at $55,010,000 after acquiring an additional 38,125 shares in the last quarter. Finally, Epoch Investment Partners Inc. boosted its holdings in shares of Natus Medical by 68.3% in the first quarter. Epoch Investment Partners Inc. now owns 1,110,932 shares of the medical equipment provider’s stock valued at $43,604,000 after acquiring an additional 450,698 shares in the last quarter. 92.66% of the stock is currently owned by institutional investors and hedge funds.

Shares of Natus Medical Incorporated (NASDAQ BABY) opened at 40.15 on Wednesday. Natus Medical Incorporated has a one year low of $31.65 and a one year high of $43.85. The stock has a market cap of $1.31 billion, a P/E ratio of 69.58 and a beta of 0.95. The stock has a 50 day moving average of $35.53 and a 200 day moving average of $36.02.

Natus Medical (NASDAQ:BABY) last released its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.01. Natus Medical had a net margin of 4.20% and a return on equity of 12.09%. The business had revenue of $122.20 million for the quarter, compared to analysts’ expectations of $121.99 million. During the same quarter last year, the company earned $0.39 EPS. The company’s revenue for the quarter was up 27.3% compared to the same quarter last year. Equities analysts expect that Natus Medical Incorporated will post $1.70 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.com-unik.info/2017/10/11/thrivent-financial-for-lutherans-has-745000-stake-in-natus-medical-incorporated-baby.html.

In related news, Director William M. Moore sold 3,000 shares of the stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $34.10, for a total value of $102,300.00. Following the sale, the director now owns 30,410 shares of the company’s stock, valued at approximately $1,036,981. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Robert A. Gunst sold 4,400 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $35.17, for a total transaction of $154,748.00. Following the completion of the sale, the director now directly owns 50,850 shares in the company, valued at approximately $1,788,394.50. The disclosure for this sale can be found here. 5.50% of the stock is owned by company insiders.

Several brokerages have recently weighed in on BABY. BidaskClub downgraded shares of Natus Medical from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Zacks Investment Research raised shares of Natus Medical from a “sell” rating to a “hold” rating in a report on Friday, September 22nd. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. Natus Medical presently has an average rating of “Hold” and an average price target of $48.00.

Natus Medical Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

What are top analysts saying about Natus Medical Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Natus Medical Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit